Ralliant Corporation (NYSE:RAL) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Ralliant Corporation (NYSE:RAL) have received an average recommendation of “Hold” from the twelve research firms that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $50.50.

Several brokerages have recently commented on RAL. Oppenheimer dropped their target price on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Zacks Research downgraded shares of Ralliant from a “hold” rating to a “strong sell” rating in a research report on Monday, February 9th. Citigroup reduced their target price on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a report on Friday, February 6th. Royal Bank Of Canada lowered their price target on Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a report on Friday, February 6th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $45.00 price objective on shares of Ralliant in a research note on Friday, February 6th.

Insider Activity at Ralliant

In related news, Director Kate Mitchell bought 2,350 shares of the firm’s stock in a transaction on Tuesday, February 10th. The shares were purchased at an average price of $42.48 per share, with a total value of $99,828.00. Following the completion of the purchase, the director owned 8,411 shares in the company, valued at $357,299.28. This represents a 38.77% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Anelise Angelino Sacks purchased 2,000 shares of the company’s stock in a transaction dated Monday, February 9th. The stock was purchased at an average price of $41.25 per share, with a total value of $82,500.00. Following the completion of the purchase, the director directly owned 5,403 shares in the company, valued at $222,873.75. The trade was a 58.77% increase in their position. The SEC filing for this purchase provides additional information. Over the last three months, insiders have bought 8,145 shares of company stock worth $332,233.

Institutional Trading of Ralliant

Hedge funds have recently made changes to their positions in the company. Danske Bank A S bought a new position in shares of Ralliant in the fourth quarter valued at approximately $25,000. Westfuller Advisors LLC purchased a new stake in Ralliant in the 3rd quarter valued at $26,000. Palisade Asset Management LLC bought a new position in Ralliant during the 3rd quarter valued at $26,000. V Square Quantitative Management LLC purchased a new position in Ralliant during the 4th quarter worth $26,000. Finally, Allworth Financial LP grew its stake in shares of Ralliant by 134.4% in the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after acquiring an additional 293 shares in the last quarter.

Ralliant Price Performance

Shares of NYSE RAL opened at $45.86 on Wednesday. The business has a fifty day moving average price of $49.49 and a two-hundred day moving average price of $46.59. The stock has a market capitalization of $5.12 billion and a PE ratio of 23.40. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. Ralliant has a fifty-two week low of $37.27 and a fifty-two week high of $57.02.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to the consensus estimate of $543.04 million. The business’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be issued a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. Ralliant’s payout ratio is 10.20%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.